NCT01512550

Brief Summary

The purpose of this prospective, randomized study is to evaluate the importance of restoring the exact individual hip biomechanics during total hip arthroplasty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2010

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 6, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 19, 2012

Completed
5.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

September 28, 2017

Status Verified

September 1, 2017

Enrollment Period

1.9 years

First QC Date

January 6, 2012

Last Update Submit

September 26, 2017

Conditions

Keywords

Radiostereometric Analysis (RSA)Total hip arthroplasty (THA)Hip anatomyHip biomechanics

Outcome Measures

Primary Outcomes (1)

  • Radiostereometric Analysis (RSA)

    This will measure the change in migration (translation and rotation around the x-, y- and z-axis of the hip) over time from baseline which is the direct postoperative examination and up to 2 years postoperatively. The migration pattern over a 2-year period can predict the long-term fate of the prosthesis

    First postoperative day(reference examination), 14 days, 3 months, 1 and 2 years

Secondary Outcomes (3)

  • Gait analysis

    Preoperatively (3-4 weeks) and 1 year postoperatively

  • Computer Tomography (CT)

    Preoperatively (3-4 weeks) and 1 year postoperatively

  • General and hip specific health questionnaires

    preoperatively (3-4 weeks), 1 and 2 years postoperatively

Study Arms (3)

instrumented hip guide technique

ACTIVE COMPARATOR

A mechanical device used to measure and decide how the hip prosthesis (ABG II modular) should be implanted

Procedure: GF hip guideDevice: ABG II modular femoral component

conventional measuring technique

NO INTERVENTION

Standard way of implanting the prosthesis (ABG II standard) without special measuring device or computer navigation technique

computer assisted navigation

ACTIVE COMPARATOR

A method to use computer navigation when positioning and sizing the hip prosthesis (ABG II modular).

Procedure: Stryker Navigation SystemDevice: ABG II modular femoral component

Interventions

GF hip guidePROCEDURE

Using GF hip guide to measure and control the peroperative positioning of the hip stem

Also known as: Instrument designed by the investigators
instrumented hip guide technique

Using Orthomap Modular Hip Software to navigate the operation

Also known as: Stryker Orthomap Hip Navigation System
computer assisted navigation

A hip prosthesis made by Stryker. It has the same basic shape as the ABG II femoral component but has a modular neck system allowing it to better follow the patient specific hip anatomy regarding offset, varus-valgus angle and rotation in the anteroposterior plane.

Also known as: ABG™II modular Cementless Hip System
computer assisted navigationinstrumented hip guide technique

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Osteoarthritis (OA) of the hip necessitating primary total hip arthroplasty (THA)
  • Male and non-pregnant female patients
  • Hip bone quality and morphology suitable for uncemented THA
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow-up.
  • Patients who are capable of, and have given informed consent for participation in the study.

You may not qualify if:

  • Rheumatoid arthritis
  • Malignant disease
  • Severe osteoporosis
  • Patients with active infection
  • Patients with malignancy
  • Prior major surgery in the hip to be operated on
  • Peroperative fracture
  • Hip prosthesis or grossly distorted hip anatomy in the contralateral hip.
  • Ongoing corticosteroid (oral) or immunosuppressive medication
  • Personal disorders (dementia, alcohol or drug abuse etc) suspected of making completion of the trial uncertain.
  • Patients with concurrent illnesses which are likely to affect their outcome.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopedics, Skane University Hospital, Lund University

Lund, 22185, Sweden

Location

Related Publications (3)

  • Esbjornsson AC, Kiernan S, Mattsson L, Flivik G. Geometrical restoration during total hip arthroplasty is related to change in gait pattern - a study based on computed tomography and three-dimensional gait analysis. BMC Musculoskelet Disord. 2021 Apr 20;22(1):369. doi: 10.1186/s12891-021-04226-4.

  • Kiernan S, Kaptein B, Flivik C, Sundberg M, Flivik G. Unexpected varus deformity and concomitant metal ion release and MRI findings of modular-neck hip stems: descriptive RSA study in 75 hips with 8 years' follow-up. Acta Orthop. 2021 Feb;92(1):67-73. doi: 10.1080/17453674.2020.1853387. Epub 2020 Dec 10.

  • Kiernan S, Geijer M, Sundberg M, Flivik G. Effect of symmetrical restoration for the migration of uncemented total hip arthroplasty: a randomized RSA study with 75 patients and 5-year follow-up. J Orthop Surg Res. 2020 Jun 17;15(1):225. doi: 10.1186/s13018-020-01736-0.

MeSH Terms

Conditions

Osteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Gunnar Flivik, MD PhD

    Dept of Orthopedics, Skane University Hospital, Lund University, Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, MD PhD

Study Record Dates

First Submitted

January 6, 2012

First Posted

January 19, 2012

Study Start

January 1, 2010

Primary Completion

December 1, 2011

Study Completion

September 1, 2017

Last Updated

September 28, 2017

Record last verified: 2017-09

Locations